Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

FDA To Track Sales Of Antibiotics To Livestock Farmers

XTALKS VITALS NEWS

Fatter livestock leads to increased food production, which can be a powerful motivator to encourage unnecessary antibiotic use.

Share this!

May 11, 2016 | by Sarah Massey, M.Sc.

The US Food and Drug Administration (FDA) has recently released its final rule requiring pharmaceutical companies to report sales data for all antibiotics used in various types of food-producing livestock. The rule – which goes into effect in 60 days – could help the agency understand how the drugs are used to raise hogs, cattle, chickens, or turkeys destined for human consumption.

Consumer groups and lawmakers have put considerable pressure on the FDA to collect and analyze this data to determine its contribution to the growing problem of antibiotic resistance. According to the Centers for Disease Control and Prevention (CDC), antibiotic resistance has contributed to 2 million cases of illness and 23,000 deaths in the US.

The National Resources Defense Council reports that approximately 70 percent of antibiotics used to treat humans, are also given to livestock. While antibiotics are given to food-producing livestock prophylactically to prevent disease, they’re also used to promote weight gain.

Fatter livestock leads to increased food production, which can be a powerful motivator to encourage unnecessary antibiotic use. As many antibiotics are approved both to treat disease and to encourage growth, producers are free to administer the drugs to their animals.



“If you can look at sales data by species, you can see what food producers are doing with antibiotics,” said Gail Hansen, a public health consultant who specializes in antibiotic resistance and infectious disease. “This isn’t a perfect plan, because sales data doesn’t exactly correlate with antibiotic use, but it can provide useful insight into trends.”

This is the first time the FDA has had access to data which sheds light on how antibiotics are being used by food producers. Before now, the agency could only track total usage of each class of antibiotics in livestock.

A recent report issued by the FDA found a four percent increase in domestic antibiotic use between 2013 and 2014, and a 22 percent increase between 2009 and 2014. According to a study published in 2015, the amount of antibiotics consumed by food-producing livestock is expected to rise by 20 percent between 2010 and 2030.

“This information will further enhance FDA’s ongoing activities related to slowing the development of antimicrobial resistance to help ensure that safe and effective antimicrobial new animal drugs will remain available for use in human and animal medicine,” said Dr. William Flynn, deputy director for science policy in the FDA’s Center for Veterinary Medicine.


Keywords: FDA, Antibiotic Resistance, Food Production


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Amgen Identifies Issue with Patient Access to PCSK9 Inhibitor

March 23, 2017 - Most US patients hoping to get their PCSK9 inhibitor medications covered by their prescription drug plan are being denied, according to two new studied conducted by Amgen.

Featured In: Biotech News


Smartphone App Created Using Apple’s ResearchKit Used to Conduct Asthma Clinical Studies

March 22, 2017 - Researchers at the Icahn School of Medicine at Mount Sinai have conducted a large-scale, observational study of asthma patients using the Apple ResearchKit framework and the Asthma Health app on patients’ iPhones.

Featured In: Clinical Trials News


IBS Patients Taking Viberzi May Be at Increased Risk of Pancreatitis

March 22, 2017 - According to a recent drug safety communication issued by the US Food and Drug Administration (FDA), patients with irritable bowel syndrome (IBS) with diarrhea should not be treated using Viberzi (eluxadoline), if they do not have a gallbladder.

Featured In: Drug Safety News

LEAVE A COMMENT
 
  
THE XTALKS VITALS LIFE SCIENCE BLOG

Will Pharmaceutical Serialization Solve All of Our Drug Counterfeiting Problems?

REGISTER FOR THESE WEBINARS

How to Improve the Speed and Efficiency of Your Clinical Trials


High Performance Computing for High Content Screening - A Case Study


The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review


Treatment of Psoriasis: Improvements Through Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.